Your browser doesn't support javascript.
loading
The Antioxidant Transcription Factor Nrf2 in Cardiac Ischemia-Reperfusion Injury.
Mata, Ana; Cadenas, Susana.
Affiliation
  • Mata A; Centro de Biología Molecular "Severo Ochoa" (CSIC/UAM), 28049 Madrid, Spain.
  • Cadenas S; Instituto de Investigación Sanitaria Princesa (IIS-IP), 28006 Madrid, Spain.
Int J Mol Sci ; 22(21)2021 Nov 03.
Article in En | MEDLINE | ID: mdl-34769371
ABSTRACT
Nuclear factor erythroid-2 related factor 2 (Nrf2) is a transcription factor that controls cellular defense responses against toxic and oxidative stress by modulating the expression of genes involved in antioxidant response and drug detoxification. In addition to maintaining redox homeostasis, Nrf2 is also involved in various cellular processes including metabolism and inflammation. Nrf2 activity is tightly regulated at the transcriptional, post-transcriptional and post-translational levels, which allows cells to quickly respond to pathological stress. In the present review, we describe the molecular mechanisms underlying the transcriptional regulation of Nrf2. We also focus on the impact of Nrf2 in cardiac ischemia-reperfusion injury, a condition that stimulates the overproduction of reactive oxygen species. Finally, we analyze the protective effect of several natural and synthetic compounds that induce Nrf2 activation and protect against ischemia-reperfusion injury in the heart and other organs, and their potential clinical application.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myocardial Reperfusion Injury / NF-E2-Related Factor 2 / Antioxidants Limits: Animals / Humans Language: En Journal: Int J Mol Sci Year: 2021 Type: Article Affiliation country: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myocardial Reperfusion Injury / NF-E2-Related Factor 2 / Antioxidants Limits: Animals / Humans Language: En Journal: Int J Mol Sci Year: 2021 Type: Article Affiliation country: Spain